osis ‚¨ç60%
diameter reduction, optimal medical therapy is indicated. There are no data to support CAS or CEA in this
patient group (GRADE 1, Level of Evidence B).
2. In most patients with carotid stenosis who are candidates for intervention, CEA is preferred to CAS for
reduction of all-cause stroke and periprocedural death
(GRADE 1, Level of Evidence B). Data from CREST
suggest that